Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$4.9 - $6.83 $29,110 - $40,577
-5,941 Reduced 4.89%
115,602 $614,000
Q2 2020

Aug 13, 2020

SELL
$2.58 - $12.1 $53,743 - $252,055
-20,831 Reduced 14.63%
121,543 $1.22 Million
Q1 2020

May 13, 2020

SELL
$1.2 - $4.52 $8,559 - $32,241
-7,133 Reduced 4.77%
142,374 $387,000
Q3 2019

Nov 13, 2019

SELL
$1.43 - $3.81 $23,509 - $62,636
-16,440 Reduced 9.91%
149,507 $226,000
Q2 2019

Aug 13, 2019

SELL
$3.23 - $5.41 $63,275 - $105,981
-19,590 Reduced 10.56%
165,947 $667,000
Q1 2019

May 13, 2019

SELL
$3.63 - $6.06 $90,466 - $151,027
-24,922 Reduced 11.84%
185,537 $798,000
Q4 2018

Feb 12, 2019

SELL
$3.76 - $14.16 $324,578 - $1.22 Million
-86,324 Reduced 29.09%
210,459 $1.21 Million
Q2 2018

Aug 13, 2018

BUY
$10.42 - $13.74 $3.09 Million - $4.08 Million
296,783 New
296,783 $3.52 Million

Others Institutions Holding ADAP

About Adaptimmune Therapeutics PLC


  • Ticker ADAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 163,370,000
  • Market Cap $73.5M
  • Description
  • Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...
More about ADAP
Track This Portfolio

Track Ws Management Lllp Portfolio

Follow Ws Management Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ws Management Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Ws Management Lllp with notifications on news.